Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.37 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.37 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4637662 | 1.00 | AKR1C1 (0.47) | AKR1C1OPRM1OPRL1LMNAHTT | |
| SCHEMBL4637584 | 1.00 | AKR1C1 (0.47) | AKR1C1OPRM1OPRL1LMNAHTT | |
| Ammonia Solution, Strong SCHEMBL6650400 | 0.98 | AKR1C1 (0.45) | AKR1C1OPRM1OPRL1LMNAHTT | |
| SCHEMBL5665997 | 0.86 | AKR1C1 (0.40) | AKR1C1OPRM1OPRL1LMNAHTT | |
| Potassium Ion SCHEMBL11295824 | 0.85 | AKR1C1 (0.38) | AKR1C1OPRM1OPRL1LMNAHTT | |
| SCHEMBL6435655 | 0.85 | AKR1C1 (0.39) | AKR1C1OPRM1OPRL1LMNAHTT | |
| SCHEMBL5180168 | 0.83 | LDHA (0.43) | AKR1C1OPRM1OPRL1LMNAHTT | |
| SCHEMBL9852819 | 0.81 | L3MBTL1 (0.42) | LMNAALDH1A1CHRNB2SLC6A2CHRNB4 | |
| SCHEMBL7806202 | 0.81 | HSD11B1 (0.46) | CHRNB2SLC6A2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL8765171 | 0.81 | LMNA (0.41) | AKR1C1OPRM1OPRL1LMNAHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2665734-B1 | METHOD FOR THE MANUFACTURE OF COMPOUNDS CONTAINING AN alpha-OXY PHOSPHORUS GROUP | STRAITMARK HOLDING AG (CH) | 2016-06-29 | — | — | EP | claimed |
| EP-2110118-B1 | Malodour reducing composition and uses thereof | TAKASAGO PERFUMERY CO LTD (JP) | 2014-11-19 | — | — | EP | claimed |
| EP-1754748-B1 | Fragrance-emitting rubber composition for tire | KUMHO TIRE CO INC (KR) | 2010-09-29 | — | — | EP | claimed |
| EP-2110118-A1 | Malodour reducing composition and uses thereof | Takasago International Corporation (JP) | 2009-10-21 | — | — | EP | claimed |
| US-20090257973-A1 | MALODOR REDUCING COMPOSITION, FRAGRANCE COMPOSITION AND PRODUCT COMPRISING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-15 | — | — | US | claimed |
| EP-1601778-B1 | STEREOSELECTIVE CHEMOENZYMATIC PROCESS FOR PREPARING OPTICALLY ENRICHED PHENYLGLYCIDATES | COUNCIL SCIENT IND RES (IN) | 2008-07-02 | — | — | EP | claimed |
| CN-101096345-A | Method for preparing chirality 2-hydroxyl group-3-amino-benzene ethylformic acid or its ester | TIANJIN TASLY GROUP CO LTD (CN) | 2008-01-02 | — | — | CN | claimed |
| EP-1601778-A1 | STEREOSELECTIVE CHEMOENZYMATIC PROCESS FOR PREPARING OPTICALLY ENRICHED PHENYLGLYCIDATES | Council of Scientific and Industrial Research (IN) | 2005-12-07 | — | — | EP | claimed |
| WO-2004087932-A2 | ENZYMATIC RESOLUTION OF (±) METHYL TRANS-3-PHENYL GLYCIDATE | SHASUN CHEMICALS AND DRUGS LIMITED (IN) | 2004-10-14 | — | — | WO | claimed |
| WO-2004081219-A1 | STEREOSELECTIVE CHEMOENZYMATIC PROCESS FOR PREPARING OPTICALLY ENRICHED PHENYLGLYCIDATES | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-09-23 | — | — | WO | claimed |
| EP-0860439-B1 | Process for preparing an optically active phenylglycidyl acid derivative | DSM NV (NL) | 2001-06-13 | — | — | EP | claimed |
| US-6025506-A | Process for preparing an optically active phenylglycidyl acid derivative | DSM N.V. (NL) | 2000-02-15 | — | — | US | claimed |
| EP-0860439-A1 | Process for preparing an optically active phenylglycidyl acid derivative | DSM N.V. (NL) | 1998-08-26 | — | — | EP | claimed |
| EP-0343714-B1 | Phenylglycidate stereoisomers, conversion products thereof with e.g. 2-nitrothiophenol and preparation of diltiazem | DSM NV (NL) | 1994-11-02 | — | — | EP | claimed |
| EP-0343714-A1 | Phenylglycidate stereoisomers, conversion products thereof with e.g. 2-nitrothiophenol and preparation of diltiazem | DSM N.V. (NL) | 1989-11-29 | — | — | EP | claimed |
| JP-2109995-A | — | — | None | — | — | JP | disclosed |
| JP-11349584-A | — | — | None | — | — | JP | disclosed |
| EP-0198397-A2 | Method of producing L-phenylalanine | KURARAY CO., LTD. (JP) | 1986-10-22 | — | — | EP | disclosed |
| US-4351952-A | Process for preparing phenyl pyruvic acids | MONTEDISON S.P.A. (IT) | 1982-09-28 | — | — | US | disclosed |
| JP-H00568588-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090257973-A1 | MALODOR REDUCING COMPOSITION, FRAGRANCE COMPOSITION AND PRODUCT COMPRISING THE SAME | AKR1C4, AKR1C3, AKR1C1 | AKR1C1 3/4885OPRM1 460/4885OPRL1 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.